Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1361 (LINC01361) is a long non-coding RNA gene that does not produce a protein product and is transcribed in intergenic regions of the human genome[1][5]. LINC01361 is part of the lincRNA family, which is known for diverse regulatory functions, such as modulation of gene expression, chromatin organization, RNA stability, and enhancer-like activities[5][7]. However, there is currently no direct evidence or functional study specific to LINC01361's role in human biology or disease, and it is not recognized as a therapeutic target, receptor, enzyme, transporter, or druggable protein at this time[1][5]. There are no known interacting drugs, mechanisms of action for drug targeting, or biomarker roles ascribed to LINC01361[1]. It is used mainly as a nomenclature entity in genomic annotation projects, with biological functions inferred from broader lincRNA studies[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1361 (LINC01361).